Outcome of pediatric patients with Langerhans cell histiocytosis treated with 2 chlorodeoxyadenosine: a nationwide survey in Japan

This publication has 21 references indexed in Scilit:

• Improved outcome of refractory Langerhans cell histiocytosis in children with hematopoietic stem cell transplantation in Japan
  Bone Marrow Transplantation, 2009
• 2′‐chlorodeoxyadenosine (2‐CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH‐S‐98 protocol of the histiocyte society
  Pediatric Blood & Cancer, 2009
• The role of BMT in childhood histiocytoses
  Bone Marrow Transplantation, 2008
• Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2‐chlorodeoxyadenosine
  Pediatric Blood & Cancer, 2007
• Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine
  Leukemia & Lymphoma, 2006
• Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction
  European Journal Of Cancer, 2005
• Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas: Results of a Japanese Phase II Study
  International Journal of Hematology, 2004
• 2-Chlorodeoxyadenosine Therapy for Disseminated Langerhans Cell Histiocytosis
  Mayo Clinic Proceedings, 2003
• Atypical Cellular Disorders
  Hematology-American Society Hematology Education Program, 2002
• 2-Chlorodeoxyadenosine to Treat Refractory Histiocytosis X
  New England Journal of Medicine, 1993